Interleukin‑15: A potent adjuvant enhancing the efficacy of an autologous whole‑cell tumor vaccine against Lewis lung carcinoma

Chen,Xi; Ni,Jie; Meng,Hui; Li,Dandan; Wei,Yuquan; Luo,Yan; Wu,Yang

doi:10.3892/mmr.2014.2474

Interleukin‑15: A potent adjuvant enhancing the efficacy of an autologous whole‑cell tumor vaccine against Lewis lung carcinoma

Authors:
- Xi Chen
- Jie Ni
- Hui Meng
- Dandan Li
- Yuquan Wei
- Yan Luo
- Yang Wu
View Affiliations

Affiliations: State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan 610041, P.R. China
Published online on: August 8, 2014 https://doi.org/10.3892/mmr.2014.2474
Pages: 1828-1834

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Lung cancer is a major cause of cancer‑associated mortality worldwide due to its limited response rate to current chemotherapy and radiation, thus immunotherapy is rapidly becoming the most promising approach. Although the highly specific tumor‑associated antigen of lung cancer has been found, autologous whole‑cell tumor vaccines remain indispensable in the development of therapeutic cancer vaccines. Interleukin (IL)‑15 is a T helper type 1 cytokine that has been demonstrated to have a marked antitumor immune response and the potential ability to reverse the host tolerance of tumor antigens in certain preclinical trials. In the present study, a cationic liposome encapsulating IL‑15 gene‑loaded plasmid acted as an adjuvant of an autologous whole‑cell tumor vaccine by subcutaneous injection. The combination immunotherapy resulted in significant inhibition of tumor growth without side effects in the preventive tumor inhibition and adoptive therapy study. Cytotoxic lymphocyte assay detection of the serum antigen and cytokines using an enzyme‑linked immunosorbent assay suggested that the IL‑15 gene can significantly improve the cellular immune response and humoral immune response provoked by autologous whole‑cell tumor vaccines. These results demonstrated that the IL‑15 gene was an effective adjuvant of autologous whole‑cell tumor vaccines against mouse lung cancer and may provide an attractive vaccine strategy for cancer immunotherapy.

View Figures

View References

1	Pardoll DM: Cancer vaccines. Nat Med. 4:525–531. 1998. View Article : Google Scholar
2	Van Der Bruggen P, Zhang Y, Chaux P, et al: Tumor-specific shared antigenic peptides recognized by human T cells. Immunol Rev. 188:51–64. 2002.PubMed/NCBI
3	Ward S, Casey D, Labarthe MC, et al: Immunotherapeutic potential of whole tumour cells. Cancer Immunol Immunother. 51:351–357. 2002. View Article : Google Scholar
4	Le DT, Pardoll DM and Jaffee EM: Cellular vaccine approaches. Cancer J. 16:304–310. 2010. View Article : Google Scholar : PubMed/NCBI
5	Belardelli F, Ferrantini M, Parmiani G, Schlom J and Garaci E: International meeting on cancer vaccines: how can we enhance efficacy of therapeutic vaccines? Cancer Res. 64:6827–6830. 2004. View Article : Google Scholar
6	Grabstein KH, Eisenman J, Shanebeck K, et al: Cloning of a T ell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science. 264:965–968. 1994. View Article : Google Scholar : PubMed/NCBI
7	Ku CC, Murakami M, Sakamoto A, Kappler J and Marrack P: Control of homeostasis of CD8⁺ memory T cells by opposing cytokines. Science. 288:675–678. 2000.PubMed/NCBI
8	Becker TC, Wherry EJ, Boone D, et al: Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med. 195:1541–1548. 2002. View Article : Google Scholar : PubMed/NCBI
9	Zhang X, Sun S, Hwang I, Tough DF and Sprent J: Potent and selective stimulation of memory-phenotype CD8⁺ T cells in vivo by IL-15. Immunity. 8:591–599. 1998. View Article : Google Scholar : PubMed/NCBI
10	Prlic M, Blazar BR, Farrar MA and Jameson SC: In vivo survival and homeostatic proliferation of natural killer cells. J Exp Med. 197:967–976. 2003. View Article : Google Scholar : PubMed/NCBI
11	Carson WE, Giri JG, Lindemann MJ, et al: Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med. 180:1395–1403. 1994. View Article : Google Scholar : PubMed/NCBI
12	Basak GW, Zapala L, Wysocki PJ, Mackiewicz A, Jakobisiak M and Lasek W: Interleukin 15 augments antitumor activity of cytokine gene-modified melanoma cell vaccines in a murine model. Oncology Rep. 19:1173–1179. 2008.PubMed/NCBI
13	Christensen D, Korsholm KS, Andersen P and Agger EM: Cationic liposomes as vaccine adjuvants. Expert Rev Vaccine. 10:513–521. 2011. View Article : Google Scholar : PubMed/NCBI
14	Gursel M and Gregoriadis G: Interleukin-15 acts as an immunological co-adjuvant for liposomal antigen in vivo. Immunol Lett. 55:161–165. 1997. View Article : Google Scholar : PubMed/NCBI
15	Ge W, Li Y, Li ZS, et al: The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following peroral administration route. Cancer Immunol Immunother. 58:201–208. 2009. View Article : Google Scholar
16	Yang YW, Wu CA and Morrow WJ: Cell death induced by vaccine adjuvants containing surfactants. Vaccine. 22:1524–1536. 2004. View Article : Google Scholar : PubMed/NCBI
17	Lee JC, Cevallos AM, Naeem A, Lennard-Jones JE and Farthing MJ: Detection of anti-colon antibodies in inflammatory bowel disease using human cultured colonic cells. Gut. 44:196–202. 1999. View Article : Google Scholar : PubMed/NCBI
18	Kelso A, Troutt AB, Maraskovsky E, et al: Heterogeneity in lymphokine profiles of CD4⁺ and CD8⁺ T cells and clones activated in vivo and in vitro. Immunological Rev. 123:85–114. 1991. View Article : Google Scholar : PubMed/NCBI
19	Lin SJ, Cheng PJ and Hsiao SS: Effect of interleukin-15 on effector and regulatory function of anti-CD3/anti-CD28-stimulated CD4(+) T cells. Bone Marrow Transplant. 37:881–887. 2006. View Article : Google Scholar : PubMed/NCBI
20	Armitage RJ, Macduff BM, Eisenman J, Paxton R and Grabstein KH: IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol. 154:483–490. 1995.PubMed/NCBI
21	Angiolillo AL, Kanegane H, Sgadari C, Reaman GH and Tosato G: Interleukin-15 promotes angiogenesis in vivo. Biochem Biophys Research Commun. 233:231–237. 1997. View Article : Google Scholar : PubMed/NCBI
22	Seike M, Yanaihara N, Bowman ED, et al: Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier. J Natl Cancer Inst. 99:1257–1269. 2007. View Article : Google Scholar : PubMed/NCBI